<mediadc-video-embed data-state="{"cms.site.owner":{"_ref":"00000161-3486-d333-a9e9-76c6fbf30000","_type":"00000161-3461-dd66-ab67-fd6b93390000"},"cms.content.publishDate":1655391139889,"cms.content.publishUser":{"_ref":"00000168-ed87-defd-a17f-fdd754cd0002","_type":"00000161-3461-dd66-ab67-fd6b933a0007"},"cms.content.updateDate":1655391139889,"cms.content.updateUser":{"_ref":"00000168-ed87-defd-a17f-fdd754cd0002","_type":"00000161-3461-dd66-ab67-fd6b933a0007"},"rawHtml":"

var _bp = _bp||[]; _bp.push({ "div": "Brid_55391127", "obj": {"id":"27789","width":"16","height":"9","video":"1032720"} }); ","_id":"00000181-6d00-d082-a1ad-7ff92c940000","_type":"2f5a8339-a89a-3738-9cd2-3ddf0c8da574"}”>Video Embed
Ivermectin, an anti-parasitic drug that gained popularity as a COVID-19 treatment, provided no significant benefit in alleviating symptoms or preventing hospitalizations and deaths, a new study found.